Robots let Ariz. Mayo Clinic doctors care remotely

TUCSON -- Starting in October, Phoenix-based neurology specialist Dr. Bart Demaerschalk will be able to roam the halls of Casa Grande Regional Medical Center, look into the eyes of stroke patients, diagnose conditions and consult with colleagues.

And he'll do it all from Phoenix using a joystick-like tool while looking at his computer monitor. His patients will be looking right back at him.

"I use a joystick device," he said. "It's much like a video game. It allows me to drive the robot in another environment."

Demaerschalk is medical director of the Mayo Clinic's telestroke system, which consists of a mobile robot doctors can control, adjust and speak through. ER doctors in Casa Grande will be able to contact the Mayo Clinic staff on a telestroke hotline.

The hospital, at 1800 E. Florence Blvd., in Casa Grande, is 43 miles from Marana.

Using telestroke, doctors can travel with other members of the health-care team throughout the hospital, moving from room to room and through elevators.

The Mayo Clinic developed the technology to care for stroke patients in rural settings. Demaerschalk said stroke neurologists and doctors working at the remote sites have used telestroke together to diagnose strokes with 96 percent accuracy in 1,000 cases.

The Casa Grande hospital is one of 11 in the network. The Mayo Clinic started the program in 2005.

The technology is already in hospitals in Bisbee, Cottonwood, Flagstaff, Globe, Kingman, Parker, Phoenix, Show Low, Yuma and Phoenix, as well as St. Joseph, Mo.

In addition to seeing patients himself, Demaerschalk and six other doctors in a rotation will have access to patients' brain scans to look for damage from blocked arteries or hemorrhages.

Read the rest here:
Robots let Ariz. Mayo Clinic doctors care remotely

UB Medical School Names New Chair of Microbiology and Immunology

News Release

Bangs joins the UB School of Medicine and Biomedical Sciences from the University of Wisconsin-Madison Medical School.

Download JPEG

Release Date: September 27, 2012

BUFFALO, N.Y. -- James (Jay) D. Bangs, PhD, professor of medical microbiology and immunology at the University of Wisconsin-Madison Medical School and an expert in the cell biology of the agent that causes African sleeping sickness, has been appointed the Grant T. Fisher Professor and Chair of the Department of Microbiology and Immunology at the University at Buffalo School of Medicine and Biomedical Sciences.

The announcement brings to nine the number of new chairs and chair-level appointees recruited by Michael E. Cain, MD, UB vice president for health sciences and dean of the UB medical school, in the past four years. These national hires, Cain says, are a critical piece of his strategic vision for the medical school's future.

According to Cain, Bangs rapidly emerged as the top candidate following a comprehensive national search, possessing all the skills needed to advance the UB department and expand its basic research programs in service of UB's 2020 strategic goals. Under Bangs, Cain says, the department will enhance the excellence of its research enterprise, undergraduate and graduate student education and mentored research training programs.

Bangs succeeds J. Iain Hay, who has served as chair of the Department of Microbiology and Immunology for 20 years.

A faculty member and trainer for the microbiological doctoral training program at UW, and a member of its Center for Research and Training in Parasitic Diseases, Bangs will join UB in January 2013.

He conducts research on African trypanosomes, one-celled parasites transmitted by the tsetse fly, which cause African sleeping sickness in humans, a fatal disease that is reemerging throughout sub-Saharan Africa.

See the original post:
UB Medical School Names New Chair of Microbiology and Immunology

Translational Regenerative Medicine: Market Prospects 2012-2022

NEW YORK, Oct. 1, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Translational Regenerative Medicine: Market Prospects 2012-2022

http://www.reportlinker.com/p0595030/Translational-Regenerative-Medicine-Market-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Blood_Supply,_Tissue_Banking_and_Transplantation

Report Details

New study shows you commercial potential of regenerative treatments

See what the future holds for translational regenerative medicine. Visiongain's updated report lets you assess forecasted sales at overall world market, submarket, product and regional level to 2022.

There you investigate the most lucrative areas in that research field, industry and market. Discover prospects for tissue-engineered products, stem cell treatments and gene therapy.

We pack our study with information and analysis to help your work and save you time:

Access to present and predicted trends, with commercial opportunities and prospects revealed

Data and discussions - including our revenue forecasts to 2022 - for your research, analyses and decision making

Link:
Translational Regenerative Medicine: Market Prospects 2012-2022

Novel gene associated with Usher syndrome identified

Public release date: 1-Oct-2012 [ | E-mail | Share ]

Contact: Allison Elliott allison.elliott@uky.edu University of Kentucky

LEXINGTON, Ky. (Oct. 1, 2012) Usher syndrome is a hereditary disease in which affected individuals lose both hearing and vision. The impact of Usher syndrome can be devastating. In the United States, approximately six in every 100,000 babies born have Usher syndrome.

Several genes associated with different types of Usher syndrome have been identified. Most of these genes encode common structural and motor proteins that build sensory cells in the eye and inner ear.

In a paper to be published in the November 2012 issue of Nature Genetics, a team of researchers from multiple institutions, led by Zubair M. Ahmed from the University of Cincinnati and Cincinnati Children's Hospital Medical Center, and including Gregory Frolenkov, associate professor in the University of Kentucky College of Medicine Department of Physiology, reported a novel type of gene associated with Usher syndrome - a calcium and integrin binding protein 2 (CIB2).

Zubair M. Ahmed, Saima Riazuddin, Thomas B. Friedman and their teams have identified this gene on chromosome 15 and determined that its mutations are responsible for nonsyndromic deafness and Usher syndrome type I. CIB2 was found to be interacting with other proteins associated with Usher syndrome.

Suzanne Leal and her team at the Baylor College of Medicine found that in Pakistan, CIB2 mutations are one of the prevalent genetic causes of nonsyndromic hearing loss.

Inna Belyantseva at the National Institute on Deafness and Other Communication Disorders, the National Institutes of Health, established that CIB2 is localized at the tips of mechanosensory stereocilia of the inner ear hair cells, exactly where the conversion of sound waves into electrical signals occurs.

Frolenkov and his team at UK demonstrated that disease-associated mutations in CIB2 change the ability of this protein to bind intracellular calcium; in a zebra fish model, its loss disrupts mechanosensitivity in the hair cells.

Furthermore, Tiffany Cook, Elke Buschback and their team at University of Cincinnati knockdown CIB2 analog in Drosophila (fruit fly) eyes and observed calcium-dependent degeneration of photoreceptors and loss of sensitivity to repetitive light pulses.

Read the rest here:
Novel gene associated with Usher syndrome identified

Community responsibility for a safety culture in academic chemistry.

This is another approximate transcript of a part of the conversation I had with Chemjobber that became a podcast. This segment (from about 29:55 to 52:00) includes our discussion of what a just punishment might look like for PI Patrick Harran for his part in the Sheri Sangji case. From there, our discussion shifted to the question of how to make the culture of academic chemistry safer:

Chemjobber: One of the things that I guess Ill ask is whether you think well get justice out of this legal process in the Sheri Sangji case.

Janet: I think about this, I grapple with this, and about half the time when I do, I end up thinking that punishment and figuring out the appropriate punishment for Patrick Harran doesnt even make my top-five list of things that should come out of all this. I kind of feel like a decent person should feel really, really bad about what happened, and should devote his life forward from here to making the conditions that enabled the accident that killed Sheri Sangji go away. But, you know, maybe hes not a decent person. Who the heck can tell? And certainly, once you put things in the context where you have a legal team defending you against criminal charges that tends to obscure the question of whether youre a decent person or not, because suddenly youve got lawyers acting on your behalf in all sorts of ways that dont look decent at all.

Chemjobber: Right.

Janet: I think the bigger question in my mind is how does the community respond? How does the chemistry department at UCLA, how does the larger community of academic chemistry, how do Patrick Harrans colleagues at UCLA and elsewhere respond to all of this? I know that there are some people who say, Look, he really fell down on the job safety-wise, and in terms of creating an environment for people working on his behalf, and someone died, and he should do jail time. I dont actually know if putting him in jail changes the conditions on the outside, and Ive said that I think, in some ways, tucking him away in jail for however many months makes it easier for the people who are still running academic labs while hes incarcerated to say, OK, the problem is taken care of. The bad actor is out of the pool. Not a problem, rather than looking at what it is about the culture of academic chemistry that has us devoting so little of our time and energy to making sure were doing this safely. So, if it were up to me, if I were the Queen of Just Punishment in the world of academic chemistry, Ive said his job from here on out should be to be Safety in the Research Culture Guy. Thats what he gets to work on. He doesnt get to go forward and conduct new research on some chemical question like none of this ever happened. Because something happened. Something bad happened, and the reason something bad happened, I think, is because of a culture in academic chemistry where it was acceptable for a PI not to pay attention to safety considerations until something bad happened. And thats got to change.

Chemjobber: I think it will change. I should point out here that if your proposed punishment were enacted, it would be quite a punishment, because he wouldnt get to choose what he worked on anymore, and that, to a great extent, is the joy of academic research, that its self-directed and that there is lots and lots of freedom. I dont get to choose the research problems I work on, because I do it for money. My choices are more or less made by somebody else.

Janet: But they pay you.

Chemjobber: But they pay me.

Janet: I think Id even be OK saying maybe Harran gets to do 50% of his research on self-directed research topics. But the other 50% is he has to go be an evangelist for changing how we approach the question of safety in academic research.

Chemjobber: Right.

The rest is here:
Community responsibility for a safety culture in academic chemistry.

Chemistry test during Euro trip

WALTHAM The last time the Celtics [team stats] made a preseason trip to Europe, they won the championship. Theyre hoping history repeats, as they departed for a week-long trip to Istanbul and Milan last night.

The 2007 trip to London and Rome gave the newly formed core of Paul Pierce [stats], Kevin Garnett and Ray Allen an opportunity to develop the chemistry that helped the team win the title. The Celtics underwent a makeover this offseason Allen departed for Miami and a number of players were added and the hope is this trip yields a similar bond.

Obviously we want to work on team chemistry, Garnett said. We want to get better every time we step on the floor. From a basketball standpoint, obviously were still getting to know each other. But its bigger than that. I think the trip to Turkey will be more social. The trip to Milan will be more for the chemistry.

Coach Doc Rivers had a practical explanation for why the players grow closer on foreign trips.

The craziest thing is that their cellphones didnt work so they actually had to talk to each other on the bus, Rivers said of the 2007 trip. I thought that was nice in this new cellphone-whatever generation this is.

The well-traveled Rivers has never been to Istanbul or Milan, and was looking forward to walking around the cities. As far as the trips effect on preparation for the season, Rivers isnt as enthusiastic.

This is a little different. We scheduled the Rome trip in response to all the moves we made and we really wanted that trip to happen, Rivers said. I dont know if this one I can say I wanted it, but its something now with all the moves Im looking forward to it. I think whenever you go on a road trip, even during the season, its never a bad thing.

Rivers is more concerned with the basketball work than tourism.

Were not going to change, Rivers said. Were going to do our job. All the other stuff is secondary for me, hopefully for them, too. But this is our camp and thats the way that I view it going into it.

Rivers sees early signs of strong team chemistry, crediting Garnett for getting new players acclimated.

Link:
Chemistry test during Euro trip

Elsevier and Roche Collaborate To Integrate Proprietary Chemistry Data In Reaxys®

FRANKFURT, Germany, October 1, 2012 /PRNewswire/ --

Roche researchers expected to benefit from increased discoverability of in-house chemistry content,integrated and unified with externally validated content,directly retrievable in Reaxys

Elsevier today announced the integration of Roche propriety reaction information within Reaxys, which will run on Roche's infrastructure and inside the Roche firewall to provide high performance and security. Roche chemistry information will be securely searchable and discoverable by Roche scientists through the Reaxys user interface. The incorporation and discoverability of Roche proprietary information in Reaxys is anticipated to significantly improve Roche scientists' productivity.

With this development Roche researchers will be able to launch a single search in Reaxys across integrated internal data and experimental data published in journals and patents, with results unified and organised in a context directly relevant to the researcher workflow. The announcement comes after many months of collaboration between teams from Roche and Reaxys.

"We have been seeking to improve the discoverability of our in-house proprietary content, while at the same time avoiding investing in and maintaining an entirely new internally or externally developed system," explained Sven-Olaf Vogt, Global Head Scientific Information Management at Roche. "Working with the Reaxys team was a logical choice given the widespread adoption of Reaxys at Roche and the knowledge of the Reaxys team in chemistry content."

Mark van Mierle, Managing Director of Elsevier's Pharma and Biotech Group, added, "Our collaboration with Roche shows how we can work together with customers to serve scientist needs. Researchers want seamless, unified data streams, delivered through highly intuitive workflow tools. Our work with Roche responds directly to those needs and enables researchers to innovate more effectively by accessing data they need, through a world-leading interface."

About Reaxys

Reaxys is a workflow solution for research chemists. Offering a wealth of experimentally validated information, Reaxys combines reaction and substance data in organic, organometallic, inorganic and physical chemistry with synthesis planning. Researchers can get the information they need in a single overview, from source publications carefully selected for their importance and relevance to research chemists. Elsevier continues to engage with the chemistry community to ensure that Reaxys continues to reflect how chemists think and work. https://www.reaxys.com/info/

Reaxys and the Reaxys trademark are owned and protected by Reed Elsevier Properties SA and used under license.

About Elsevier

Go here to see the original:
Elsevier and Roche Collaborate To Integrate Proprietary Chemistry Data In Reaxys®

Massachusetts Biotechnology Council says Central Square zoning proposal would hurt life sciences

By Robert Weisman, Globe Staff

The states largest biotechnology trade group sent a letter to Cambridge city officials Monday opposing a proposal by neighborhood activists that would change zoning in an area around Central Square, which would potentially block large-scale development or expansion plans for life sciences companies.

In the letter to the chairmen of the Cambridge City Councils ordinance committee and the Cambridge Planning Board, Robert K. Coughlin, president of the Cambridge-based Massachusetts Biotechnology Council, noted that the city is home to more than 110 life sciences companies that are drawn to nearby research universities and hospitals.

The life sciences industry has always sought to be a good neighbor and active corporate citizen in the life of Cambridge, Coughlin wrote. With this commitment in mind, we encourage you to defeat the downzoning proposal. We feel that it would restrict the kind of sustainable development that brings tremendous benefits to the people of Cambridge.

Read more:
Massachusetts Biotechnology Council says Central Square zoning proposal would hurt life sciences

MacArthur Foundation bestows 23 ‘genius grants’

By MIKE THOMAS Staff Reporter/mthomas@suntimes.com October 1, 2012 5:08PM

Melody Swartz was named a MacArthur Foundation fellow. | Courtesy of the John D. and Catherine T. MacArthur Foundation

storyidforme: 37821798 tmspicid: 13869099 fileheaderid: 6386110

Updated: October 2, 2012 2:18AM

When Melody Swartz got word that shed been chosen to receive a coveted MacArthur Fellows Program award (known more commonly as a genius grant), the Switzerland-based bioengineering professor and Glen Ellyn native was in the middle of a grocery store with 80s music blaring from loudspeakers overhead.

Horrified at what the John D. and Catherine T. MacArthur Foundation representative might think of the cheesy tunes streaming through her cell phone, she dropped her shopping basket and rushed to find a quiet corner.

I was completely flabbergasted, Swartz said via email. It came completely out of the blue.

Like the rest of this years 23 awardees which include such disparate pioneers as Pulitzer Prize-winning novelist Junot Diaz, pediatric neurosurgeon Benjamin Warf and stringed-instrument bow maker Benoit Rolland Swartz, 43, will receive a total of $500,000 paid out quarterly over five years.

Since 1981, with the help of anonymous, handpicked nominators, the MacArthur Foundation has doled out hundreds of grants and many millions of dollars to artists and entrepreneurs in a variety of disciplines.

In a written summary of her achievements, the MacArthur Foundation notes that Swartzs research has important implications not only for normal tissue development and maintenance but also for cancer biology.

Read more here:
MacArthur Foundation bestows 23 ‘genius grants’

Anthony M. Payne named to the founding faculty of the Frank H. Netter MD School of Medicine at Quinnipiac University

HAMDEN, Conn., Sept. 25, 2012 /PRNewswire-USNewswire/ -- Anthony M. Payne has been appointed to the founding faculty of the Frank H. Netter MD School of Medicine at Quinnipiac University.

In his new position, Payne will be responsible for teaching physiology, histology and gross anatomy at Connecticut's newest medical school, which is expected to open on Quinnipiac's North Haven Campus. Before coming to Quinnipiac, Payne was a lecturer in the Anatomy and Cell Biology Department at the University of Florida.

"This is a tremendous opportunity," Payne said. "It's rare to have one's educational pursuits be valued so highly."

Payne earned a doctorate in physiology from Wake Forest University. He also holds a master's degree in exercise physiology from the University of Florida and a bachelor's degree in exercise science from Winthrop University. He is a member of the American Physiological Society and the American Association of Anatomists.

"I am delighted that Anthony has joined the School of Medicine," said Dr. Bruce Koeppen, founding dean of the school. "He brings the school expertise in physiology, anatomy and histology, all of which are core disciplines in our curriculum."

The Frank H. Netter MD School of Medicine is scheduled to open in the Fall of 2013, pending preliminary accreditation by the Liaison Committee on Medical Education .

The medical school, which will train primary care physicians, is aiming to become a national model of interprofessional health professions education and improve the way health care is delivered. Medical students at Quinnipiac will be part of a learning environment where they will interact with students from Quinnipiac's School of Health Sciences and School of Nursing to learn to become effective members of a primary health care team.

Quinnipiac is a private, coeducational, nonsectarian institution located 90 minutes north of New York City and two hours from Boston. The university enrolls 6,200 full-time undergraduate and 2,300 graduate students in 58 undergraduate and more than 20 graduate programs of study in its School of Business and Engineering, School of Communications, School of Education, School of Health Sciences, School of Law, Frank H. Netter MD School of Medicine, School of Nursing and College of Arts and Sciences.

SOURCE Quinnipiac University

More here:
Anthony M. Payne named to the founding faculty of the Frank H. Netter MD School of Medicine at Quinnipiac University

USCAP’s MyPath™ Announces Digital Partnership with the National Institute of Health’s PubMed

MyPath software empowers the global pathology community to quickly access scattered and ever changing information critical to diagnostic pathology. Today, our new collaboration with PubMed, which contains the National Health Institutes vast biomedical resources, continues MyPath and the United States and Canadian Academy of Pathologys (USCAP) commitment to being the resource for pathology practitioners, education and professional collaboration.

Augusta, GA (PRWEB) October 01, 2012

Today, MyPath becomes a stronger tool with the announcement of USCAPs partnership with the National Institute of Healths Pub Med library. This collaboration makes all of NIHs vast biomedical resources instantly available to MyPath and USCAP members. More importantly, content available through PubMed is also available to MyPath users to store in their own personal files, make comments, and read the comments of others including those from leading experts. This truly is a game changer for the global pathology community. It has never been easier to access the worlds premiere pathology and biomedical information, commented Jeffrey L. Myers, M.D., Chair of USCAPS Innovative Educational Products Committee.

My goal is to grow USCAPs leadership in pathology education, said USCAP Executive Vice President Bruce Smoller, We were pleased to recently announce receiving ACCMEs highest recognition for all of USCAPs educational courses. Now these courses are readily accessible through MyPath on iPad and computer, anytime, anywhere.

To connect with MyPath, log on to http://www.MyPath .uscap.org.

Company Information:

The United States and Canadian Academy of Pathology (USCAP) is the leader of pathology education excellence. Dedicated to creating and disseminating pathology research, education and collaboration, USCAP empowers doctors with the latest advances to improve their daily practices. The USCAP website: http://www.uscap.org.

jeff monks

706.733.7550 Email Information

See the original post:
USCAP’s MyPath™ Announces Digital Partnership with the National Institute of Health’s PubMed

Choose Highly Definitive Antibodies for IHC with the new Leica Biosystems Novocastra HD Menu for Breast Pathology

NEWCASTLE UPON TYNE, England, October 1, 2012 /PRNewswire/ --

Leica Biosystems announces the availability of the Novocastra HD menu for breast pathology, the first portfolio of independently qualified* antibodies from the new Novocastra HD range. Together with the FDA approval of the Leica BOND Oracle HER2 IHC System on April 18, 2012, this new menu affirms Leica Biosystems' position as a premier supplier of the most clinically important IHC systems and reagents for the diagnosis of breast cancer.

(Photo: http://photos.prnewswire.com/prnh/20121001/564961 )

The Novocastra HD menu for breast pathology comprises 37 products, developed following extensive research with pathologists and laboratory staff from around the globe. Novocastra HD products have been independently evaluated* by NordiQC in comparison with leading equivalents. Staining performance in Ready-to-Use format has been optimized on BOND instrumentation, delivering the crucial diagnostic confidence that underpins every patient diagnosis. Pathologists and laboratories can confidently select any Novocastra HD product, knowing that it has been externally benchmarked against leading equivalents for staining quality and diagnostic performance.

'Leica Biosystems strives to achieve the utmost customer satisfaction and improvement in patient care through the pursuit of excellence in quality', says Arnd Kaldowski, President of Leica Biosystems. 'The new Novocastra HD menu for breast pathology was developed to meet our customers' need for clinically relevant antibodies that deliver high quality staining and results patients can depend on.'

The Novocastra HD breast pathology menu of IHC antibodies comprises twelve[#] clones in a range of formats and volumes. Many BOND Ready-to-Use antibodies come in two sizes: 7 mL and a new 30 mL size for higher usage requirements. Liquid concentrates are available in an expanded range of sizes from 0.1 mL to 2 mL.

The Novocastra HD menu for breast pathology will be available for sale in the USA and EU from September 2012. Availablility in other regions will follow.

Leica Biosystems offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

http://www.LeicaBiosystems.com

Continue reading here:
Choose Highly Definitive Antibodies for IHC with the new Leica Biosystems Novocastra HD Menu for Breast Pathology

Nutrition North program in full effect

The Nutrition North Canada program comes into full effect today.

The program was rolled out slowly to make for a smooth transition from the old food mail program.

As of today, many non-perishable items like canned soups, canned vegetables and dry rice and pasta are no longer subsidized.

Retailers have been preparing for today's deadline for months, so prices won't jump instantly.

The North West Company owns and operates many grocery stores in Nunavut and the N.W.T. It has already secured an extra two months' supply of those non-perishables by sealift to Nunavut.

Michael McMullen, the companys vice president of northern retail, said the company has also cut down on the number of brands it carries to make room for the larger sealift order instead of building a new warehouse.

We would rather be more efficient with the resources we have available than invest money needlessly and be in a position of having to pass on those costs of construction to the customer, said McMullen.

McMullen said if prices do increase, it wouldn't be until late spring or early summer.

"It's not October 1 so much that we worry about. It's more as the sealift supply dwindles, it's more did we gauge the customer demand correctly."

Shoppers will have to wait until mid-2013 to see any potential impact on prices.

Go here to see the original:
Nutrition North program in full effect

Intertek: Cargill Feed & Nutrition Indonesia achieves prestigious GlobalGAP certification

JAKARTA--(BUSINESSWIRE)-- Cargill Feed & Nutrition (CFN) is a market leader in providing feeding programs and on-farm solutions to Indonesias growing aquaculture industry.

Having recently completed a comprehensive assessment by Intertek, an independent accredited certification body, the Cargill plant in Medan, Indonesia is the first in the group to be awarded the GlobalGAP certification for Compound Feed Manufacturing.

The GlobalGAP Standard for Compound Feed Manufacturing Version 2.1 is a reference for Good Manufacturing Practice and covers all aspects of feed manufacturing from raw material sourcing to the finished feed products used on farm. Feed sourced from a GlobalGAP certified plant is a requirement for aquaculture production, and is a demonstration of Cargills commitment to provide safe and nutritional feed solutions to its customers as part of a responsible food supply chain.

Erwin Sanusi, Cargills Total Quality Management Manager, commented: Achieving the GlobalGAP standard is aligned with Cargills strategy to support our customers need in improve food safety and promoting sustainable sourcing practices. Our manufacturing processes are built upon best practices from the Cargill group for safety, security and traceability.

Beate Heidorn, Certification Manager, Intertek Food Services, stated that her team was impressed with the overall professionalism and clear understanding of food safety that the Cargill employees showed. Earning the GlobalGAP Standard for Compound Feed Manufacturing demonstrates the strengths of Cargills internal Standard Operating Procedures (SOP) and its employees discipline in fully supporting these. This achievement shows the positive manner in which the entire business collaborates internally as well as externally with outside stakeholders.

About Cargill in Indonesia

Cargill began doing business in Indonesia in 1974 by establishing a feed mill in Bogor, West Java. Today, Cargill - which is headquartered in Jakarta - has over 10,000 employees and offices, manufacturing plants and facilities throughout the country. Business units comprise animal nutrition, cocoa, grain and oilseeds, palm oil, and sugar. Cargill is a responsible corporate citizen of Indonesia, and its local programs foster responsible and sustainable development, help protect the environment and nourish the people and possibilities that reside in local communities. For more information visit http://www.cargill.co.id

About Cargill Feed & Nutrition Indonesia

Cargill Feed Nutrition (CFN) is one of Cargill Business Unit in Indonesia. It is one of players in providing feeding programs and on-farm solutions to Indonesias livestock and aquaculture industries. CFN, Indonesia operates six modern feed mills producing high quality customized feed products. The companys portfolio includes poultry (layer and broiler), swine, dairy and aquaculture feeding programs and on-farm technical support.

About GlobalGAP

Originally posted here:
Intertek: Cargill Feed & Nutrition Indonesia achieves prestigious GlobalGAP certification

Nutrition, Prevention and the Affordable Care Act

The American Nutrition Association is hosting a panel discussion titled, "Nutrition, Prevention and the Affordable Care Act." Panelists include: Joe Walsh, Congressman from the Illinois 8th District; Joseph Mercola, D.O., a renowned physician; Barbara Bellar, MD, JD, MA, an Illinois State Senate candidate; and Laura Minzer, executive director, Healthcare Council, Illinois Chamber of Commerce.

Palatine, IL (PRWEB) October 01, 2012

The esteemed forum panelists are:

The president of the ANA - Michael Stroka, JD, MBA, MS, CCN, CNS, will moderate.

The goal of the forum is to have a respectful discussion about aspects of the Affordable Care Act which relate to nutrition, prevention and integrative medicine, Stroka said. We want to educate both the public and our local and national representatives about this massively complex piece of legislation and just how it will influence preventative care, specifically nutritional counseling and integrative medicine. We will present facts, voice concerns and listen carefully to opinions from our panelists and answer questions from audience members.

Congressman Joe Walsh of the 8th District of Illinois has been invited to participate so that he may share his efforts on patient-centered reforms in health care and hear public concerns related to prevention within the Affordable Care Act.

Dr. Joseph Mercola is a world renowned physician based in Chicago. Dr. Mercola sits on the professional advisory board of the ANA and is an expert in nutrition and its role in disease prevention.

Barbara Bellar is both a medical doctor and lawyer and has comprehensive knowledge of the Affordable Care Act (sometimes referred to as Obamacare).

Laura Minzer, in her leadership role with the Illinois Chamber of Commerce, spearheads collaborative response to state-level health reform (Affordable Care Act.)

Tammy Duckworth, Democratic candidate for U.S. Representative from the 8th District of Illinois, was invited to be a panelist, but she has another commitment.

Continued here:
Nutrition, Prevention and the Affordable Care Act

Nutrition North Canada Subsidized Foods List Takes Effect Today

OTTAWA, ONTARIO--(Marketwire - Oct 1, 2012) - The Honourable John Duncan, Minister of Aboriginal Affairs and Northern Development, announced today the implementation of the Nutrition North Canada subsidized foods list.

"For years Northerners have asked for a better alternative to the old Food Mail Program. Nutrition North Canada focuses its highest subsidy on the most nutritious, perishable foods such as fresh fruit, frozen vegetables, milk and eggs," said Minister Duncan. "The subsidized foods list implemented today reflects input received from the Nutrition North Canada Advisory Board, Northerners, nutritionists at Health Canada and other sources."

The Government of Canada has implemented accountability measures for retailers and suppliers, and compliance audits confirm that they are complying with the program. Prices have dropped by as much as 37 percent on some products, such as two litre containers of milk, and on average, there has been an eight percent drop in the cost of the Northern food basket.

"Our Government is ensuring that Northerners have improved access to quality, nutritious food," added Minister Duncan. "We are seeing stronger partnerships between communities and local stores to promote healthy eating, more opportunities for communities to learn about healthy eating and gain cooking skills, and broadened outreach to youth."

Nutrition North Canada is also funding community based nutrition education activities to increase knowledge of healthy eating and develop skills for selecting and preparing healthy foods. Nutrition education activities are underway across the North that include cooking classes, knowledge sharing on country or traditional foods between elders and youth, and healthy food tastings in local stores.

Family-friendly staples such as cheese spreads, side bacon and ice-cream are also on the subsidized foods list. The foods list, data and pricing reports, frequently asked questions and more information can be found on the Nutrition North Canada website.

The Nutrition North Canada Program is delivered in isolated, northern communities in Newfoundland and Labrador, Quebec, Ontario, Manitoba, Saskatchewan, Northwest Territories, Nunavut and Yukon.

Frequently Asked Questions

Data Reports

This release is also available on the Internet at http://www.aandc.gc.ca.

Link:
Nutrition North Canada Subsidized Foods List Takes Effect Today

Complete Nutrition Teams Up with the National Breast Cancer Foundation

OMAHA, Neb., Oct. 1, 2012 /PRNewswire/ --Complete Nutrition, a nutritional supplement retailer known for its consultative approach to health and fitness, is partnering with the National Breast Cancer Foundation (NBCF) for Breast Cancer Awareness Month.

As part of the "Empowered Pink Out" campaign, participating Complete Nutrition stores will collect donations from its customers on behalf of NBCF. As an incentive to donate, Complete Nutrition will reward customers with Complete Cash, a store credit equal to their donation amount up to $50. Customers who donate can apply the store credit to more than 200 Complete Nutrition-brand general health, weight-loss and sports nutrition products.

"This campaign will provide funding to support our mammogram and educational programs.We thank Complete Nutrition for their sponsorship and partnership," said Brent Hail, Senior VP of Development for NBCF.

Several stores will hold two-day "Pink Out" events to raise more money, offering customers store credit worth double their donation amount up to $50.

"This is a win-win partnership for everyone involved," said Amy Bailey, Complete Nutrition director of marketing. "Our customers can continue making positive life changes, only now they'll have the chance to directly support the National Breast Cancer Foundation."

For more information on Complete Nutrition, visit http://www.completenutrition.com. For more information on NBCF, visit: http://www.nationalbreastcancer.org.

About Complete Nutrition

Complete Nutrition is a network of high quality nutritional supplement retail stores whose mission is to create a safe and effective weight management, sports nutrition, and healthy aging program to help customers look better, feel better, and perform better. Since 2005, Complete Nutrition has been helping people achieve their health and wellness goals by offering exclusive supplements at affordable prices. Staff members are athletes, certified personal trainers, nutritionists, and other people with experience in the health and fitness supplement retail industry. Founder Cory Wiedel and President Ryan Zink were named finalists of the Ernst & Young Entrepreneur Of The Year 2012 Central Midwest award. Complete Nutrition recently earned the following top honors from Entrepreneur Magazine in 2012: Franchise 500 award recipient, No. 2 Top New Franchise, No. 36 Fastest-Growing Franchise. Additionally, Complete Nutrition was named to the 2011 Allbusiness.com AllStar Franchises Top 300 list. For more information about Complete Nutrition, call 866-366-5766 or visit http://www.CompleteNutrition.com.

More here:
Complete Nutrition Teams Up with the National Breast Cancer Foundation

Leading Microbiology Expert Joins BD Diagnostics in Maryland

SPARKS, Md., Oct. 1, 2012 /PRNewswire/ --BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today that Paul Bourbeau, Ph.D. has joined the Company as Director, North American Scientific Affairs, BD Diagnostics Diagnostic Systems.

Dr. Bourbeau brings experience from an impressive career in academics and clinical laboratory practice, most recently serving as Director of Microbiology, Geisinger Medical Laboratories, Danville, PA. In his new role, Dr. Bourbeau will leverage his clinical and scientific expertise to guide the molecular diagnostic and laboratory automation programs. He will be based in the Company's Sparks, MD office.

"We are very pleased to have a leading expert in clinical microbiology and infectious diseases, such as Dr. Bourbeau, joining our team," said Patrick Murray, Ph.D., Worldwide Director of Scientific Affairs, BD Diagnostics Diagnostic Systems. "His clinical perspective will be a great addition to BD as we launch our BD MAX System, BD Viper System, and BD Kiestra Microbiology Lab Automation platforms."

While at the Geisinger Medical Laboratories, Dr. Bourbeau oversaw the clinical and research programs in Microbiology, served on numerous local and national scientific committees and is currently Associate Editor, Journal of Clinical Microbiology. He received his Ph.D. degree in Microbiology at Temple University School of Medicine and completed postgraduate training in Clinical Microbiology at Hartford Hospital, Hartford, CT.

About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit http://www.bd.com.

Contact:Jamie Yacco Public Relations (201) 847-4796 Jamie_Yacco@bd.com

Read more:
Leading Microbiology Expert Joins BD Diagnostics in Maryland

The Center for Productive Longevity Announces Winners of the Nationwide Later-Life Story Contest

BOULDER, CO--(Marketwire - Oct 1, 2012) - The Center for Productive Longevity (CPL) is pleased to announce the winners of its Later-Life Story Contest, which was created to demonstrate that older people can continue to lead successful and inspirational lives. Barbara M. Traynor was chosen for the Inspirational Life Story category and Lynn Brooks for her Entrepreneurship Success Story. Both entries are available to read online at http://www.ctrpl.org/later-life-story-contest-winners. A panel of three independent judges selected the winners from many fascinating stories sent in by people 50 and older. Lynn and Barbara will each receive a prize of $1,000 and a specially designed display trophy.

In Lynn Brooks' winning essay, she wrote about beginning an organization in 1992 at age 59 called Big Apple Greeter in New York City. It is a non-profit that pairs visitors to NYC with volunteer greeters who explore the city together. This was the first "Welcome Visitor" program of its kind in the country. Today, the organization is extremely successful, but it was a challenging journey along the way. Lacking funding, support and computer skills, but holding onto a will to succeed, Lynn overcame many challenges.

Her story describes how far the organization has come. "Today we have more than 300 Greeters -- most are over 55, more than 50% work, many are multilingual, some are blind or use wheelchairs. They are ready, rain or shine, to spend two to four hours with visitors, showing them our people, culture and diversity."

Lynn also shared wonderful metrics. "In terms of success, our cup runneth over. We've had more than 120,000 visitors since we started. We've generated over two billion positive, world-wide media impressions about New York City. Ninety-five percent of our visitors give us 'extraordinary' evaluations. Our volunteer retention rate is incredibly high. We've been called the most cost-effective public relations arm in the city. We've been widely recognized, starting in our early years, with awards that run the gamut from corporations to city government, and in January we will receive the prestigious 2012 Hotel Excellence Lifetime Achievement Award." To read her story, visit: http://www.ctrpl.org/later-life-story-contest-winners.

Barbara M. Traynor's story begins with a situation that sounds familiar to many people. Yet she took some giant leaps of faith to change her life forever.

"Walking provides impetus to ponder. My 65th birthday was hovering. I was not feeling old, but sixty-five? That's major!Why I chose to walk the beach on a frigid winter afternoon is questionable, however with boots crunching on the frozen sand, gloved hands balled into my pockets, I reviewed my six-odd decades. Married at nineteen, three children by twenty-seven, moved eighteen times with a grass-is-greener spouse -- instant on-the-job-training in how to deal with transition -- and divorced after seventeen years.

"Working as an administrative assistant for over forty-five years, single mother raising three children, generated an abundant desire for freedom and travel but little savings and no pension. Life was crammed with drama and trauma. Income matched outgo. I would have to live on Social Security income alone. I screamed into the thundering surf, 'How can I afford to go anywhere? When is it my turn?' Surprise! Someone was listening.

"Arriving home, I checked my email. A message from Alaska cajoled: How about becoming a long-distance, long-term volunteer? Hmmmm -- it seemed that some organizations supplement their staff with volunteers, offering free room and board in exchange for workplace skills? WOW! That I could spend my over 65 'mystery' years this way inspired my imagination. My frozen fingers tingled. I began to rethink retirement."

At age 65, Barbara retired and drove to Alaska from Connecticut with a mission and copious notes about sites to visit along the way. The journey to be a volunteer exploded into becoming a journalist, author and speaker as well. Read her story, chock-full of adventure and inspiration at: http://www.ctrpl.org/later-life-story-contest-winners.

CPL will also select a variety of other inspirational and touching entries to post on its website.

Visit link:
The Center for Productive Longevity Announces Winners of the Nationwide Later-Life Story Contest

New study highlights the role of testosterone in longevity

In the industrialized world, women live at least five years longer, on average, than men. Scientists have attributed that difference to everything from healthier habits to hardier cells. Now, a study that analyzes the longevity of eunuchs, or castrated men, suggests that testosterone may play a part in shortening mens lives.

The idea that testosterone, the male sex hormone, affects life span isnt new. Neutered dogs and other animals that have had their sources of testosterone removed often live longer than their intact counterparts. But studies on the connection between castration and longevity in humans are harder to come by, and the results have been inconclusive. A 1969 study of institutionalized patients in Kansas found that castrated men lived an average of 14 years longer than other men in the same facility, but a 1993 study of Italian castrati (singers castrated as boys to preserve their high voices) found nothing unusual about their longevity.

Almost five years ago, biologist Kyung-Jin Min of Inha University in Inchon, South Korea, found himself considering this lack of data while watching a TV drama about eunuchs. Min began to wonder if Koreas rich historical records could shed light on the link between castration and longevity in humans.

Until the late 19th century, Korean rulers employed eunuchs to serve the royal court. These eunuchs were allowed to marry and adopt castrated boys as their sons. The Yang-Se-Gye-Bo, a genealogical record of the eunuch families, has survived, and it documents the birth and death dates and other personal details of 385 eunuchs who lived between the mid-16th century and the mid-19th century.

Min and colleagues from the National Institute of Korean History and Korea University began to pore over the Yang-Se-Gye-Bo. After painstakingly comparing it with other historical records, the team was able to identify and verify life spans for 81 of the listed eunuchs. To rule out the effects of cushy conditions on longevity, they compared the eunuchs life spans to those of uncastrated men of similar social status living at the same time. The eunuchs outlived their uncastrated contemporaries by 14 to 19 years, the researchers report online in the journal Current Biology.

The eunuch group also boasted three centenarians among the 81 verified life spans, an unusual number considering that the current incidence of centenarians is just one in 3,500 in Japan and one in 4,400 in the United States.

I thought there were errors in our data and checked everything again, Min says. I was quite surprised by the big difference in longevity and the number of centenarians.

The study doesnt directly explain why the eunuchs lived so much longer, but it provides the strongest evidence yet that testosterone the key difference between the eunuchs and their peers in this study and a proxy for the difference between women and men plays a role, says Steven Austad, a biogerontologist at the University of Texas Health Science Center in San Antonio, who was not involved in Mins study.

This is the most thorough, well-controlled study of its kind, Austad says. The sex difference in aging and longevity is an almost unexplored area, and this study highlights that testosterone is part of the issue.

Identifying all the factors that contribute to the difference in longevity between men and women may help researchers find ways to temper their effects, Austad says. That, in turn, could help men live longer without losing any body parts in the process.

View post:
New study highlights the role of testosterone in longevity